Your browser doesn't support javascript.
loading
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors.
Cañedo, Eduardo Cepeda; Totten, Stephanie; Ahn, Ryuhjin; Savage, Paul; MacNeil, Deanna; Hudson, Jesse; Autexier, Chantal; Deblois, Genevieve; Park, Morag; Witcher, Michael; Ursini-Siegel, Josie.
Afiliação
  • Cañedo EC; Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Totten S; Division of Experimental Medicine.
  • Ahn R; Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Savage P; Division of Experimental Medicine.
  • MacNeil D; Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Hudson J; Division of Experimental Medicine.
  • Autexier C; Goodman Cancer Research Centre.
  • Deblois G; Department of Biochemistry, and.
  • Park M; Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
  • Witcher M; Department of Anatomy and Cell Biology, McGill University, Montreal, Québec, Canada.
  • Ursini-Siegel J; Lady Davis Institute for Medical Research, Montreal, Québec, Canada.
JCI Insight ; 6(4)2021 02 22.
Article em En | MEDLINE | ID: mdl-33470989
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article